Skip to main content

Peer Review reports

From: HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer

Original Submission
8 Jul 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
2 Aug 2022 Reviewed Reviewer Report
9 Aug 2022 Reviewed Reviewer Report - Luca Giacomelli
16 Sep 2022 Author responded Author comments - François CHERIFI
Resubmission - Version 4
16 Sep 2022 Submitted Manuscript version 4
20 Sep 2022 Author responded Author comments - François CHERIFI
Resubmission - Version 5
20 Sep 2022 Submitted Manuscript version 5
Publishing
5 Oct 2022 Editorially accepted
20 Oct 2022 Article published 10.1186/s12885-022-10163-9

You can find further information about peer review here.

Back to article page